ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Discussing The Future Of CRISPR-Cas: Gene Editing Takes Center Stage At CRISPRcon – PR Newswire (press release)

Discussing The Future Of CRISPR-Cas: Gene Editing Takes Center Stage At CRISPRconPR Newswire (press release)The conference is the first of its kind to bring together farmers, doctors, patients, environmentalists, consumers, nonprofits, community leader… Continue reading

2017-07-13 Michael Zand NEWS

Dog Gets Special Stem Cell Treatment To Relieve Pain – CBS Local

Continue reading

2017-07-13 Michael Zand NEWS

Dog Gets Special Stem Cell Treatment To Relieve Pain « CBS Denver – CBS Local


CBS Local

Dog Gets Special Stem Cell Treatment To Relieve Pain
CBS Local
MediVet’s stem cell therapy surpasses any other treatment options for elbow or hip dysplasia and arthritis in dogs and cats. Stem cells rebuild the cartilage in joints and reduce painful inflammation naturally. They are healing cells, naturally found …

and more »

Continue reading

2017-07-13 Michael Zand NEWS

‘We’ve reached peak antibiotics’ – Newsroom


CBS Local

Dog Gets Special Stem Cell Treatment To Relieve Pain « CBS Denver
CBS Local
A dog received stem cell treatment at the Aspen Arbor Animal Hospital in Broomfield on Wednesday.

and more »

Continue reading

2017-07-13 Michael Zand NEWS

Discussing The Future Of CRISPR-Cas: Gene Editing Takes Center Stage At CRISPRcon – SYS-CON Media (press release)


Newsroom

‘We’ve reached peak antibiotics’
Newsroom
“Taking advantage of the fact that bacteria are so good at swapping bits of DNA, we and others have shown that you can employ ‘synthetic biology‘ approaches to transfer these blueprints to a new host – a bacterium that we can grow in the lab – and a …

Continue reading

2017-07-13 Michael Zand NEWS

About CAR-T leukemia therapy, part of a new wave in cancer treatment – ABC News

Discussing The Future Of CRISPR-Cas: Gene Editing Takes Center Stage At CRISPRcon
SYS-CON Media (press release)
“Fulfilling the promise and the potential of CRISPR technology requires collaboration and thoughtful, open dialogue,” says Jennifer Doudna, professor at the University of California, Berkeley, and a pioneer in the field of CRISPR biology and genome …

and more »

Continue reading

2017-07-13 Michael Zand NEWS

Feedback from thousands of designs could transform protein engineering – Phys.Org

Phys.OrgFeedback from thousands of designs could transform protein engineeringPhys.OrgThe most recent testing led to the design of 2,788 stable protein structures and could have many bioengineering and synthetic biology applications. Their small size m… Continue reading

2017-07-13 Michael Zand NEWS

Why CAR T-cell immunotherapy is such a big deal for cancer treatment – Popular Science


Chicago Tribune

About CAR–T leukemia therapy, part of a new wave in cancer treatment
ABC News
The committee’s approval for CAR–T therapy applies to children and young adults, ages 3 to 25, with a form of leukemia called relapsed or refractory B-cell acute lymphoblastic leukemia (ALL). ALL is the most common type of cancer in children, with …
First gene therapy — ‘a true living drug’ — on the cusp of FDA approvalChicago Tribune
Novartis CAR–T Therapy Drug Recommended by FDA PanelNasdaq
FDA may approve goundbreaking cancer treatment that uses body’s immune system to fight diseaseThe Independent
Fortune –Gizmodo –FDA –New York Times
all 245 news articles »
Continue reading

2017-07-13 Michael Zand NEWS
  • 1
  • …
  • 1,499
  • 1,500
  • 1,501
  • 1,502
  • 1,503
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Popular Science

Why CAR T-cell immunotherapy is such a big deal for cancer treatment
Popular Science
The treatment is known in the medical community as CAR T-cell therapy. It involves removing some T-cells—a type of white blood cell—from a patient’s blood. Then researchers tweak the outside of each cell in the lab by adding a receptor called CAR …
CAR–T gene therapy for leukemia clears FDA hurdleCBS News
A New Dawn: First CAR T Cell Recommended for FDA ApprovalMedscape
FDA Panel Unanimously Recommends Approval for Novartis’ CAR T-Cell Therapy CTL019Genetic Engineering & Biotechnology News
Washington Post –FierceBiotech –ABC News –FDA
all 163 news articles »